颅内脑膜瘤手术:1995-2015年纽约州基于价值的医疗决定因素
该研究查询纽约州1995至2015年数据库,纳入14239例颅内脑膜瘤手术患者,用多变量logistic回归分析医院手术量和患者人口学特征对30天再入院、30天死亡率、延长住院时间(pLOS)和超额住院费用的影响。高手术量中心(>第75百分位)与较低的再入院率、死亡率和pLOS相关,但住院费用更高。多变量分析中,高手术量中心pLOS的比值比为0.56(P<0.0001),30天死亡率的比值比为0.39(P<0.0001)。
要点
- 高手术量中心与较低的再入院率、死亡率和pLOS相关,但住院费用更高。
- 多变量分析中,高手术量中心pLOS的比值比为0.56(P<0.0001)。
- 多变量分析中,高手术量中心30天死亡率的比值比为0.39(P<0.0001)。
核心结论
- 这项全州人口分析识别了颅内脑膜瘤手术后不良结局的患者预测因素,医院可利用这些决定因素为高危人群制定改进的医疗系统。
研究设计与样本
- 查询纽约州1995至2015年全州规划与研究合作系统数据库,纳入14239例接受颅内脑膜瘤手术的患者,使用多变量logistic回归分析医院手术量和患者人口学特征对30天再入院、30天死亡率、pLOS和超额住院费用的影响。
主要发现
- 14239例患者中,10252例(72%)在高手术量中心(>第75百分位)手术。
- 高手术量中心与较低的再入院率、死亡率和pLOS相关,但住院费用更高。
- 多变量分析中,高手术量中心pLOS的比值比为0.56(P<0.0001),30天死亡率的比值比为0.39(P<0.0001)。
- 多变量模型中与不良结局相关的患者因素包括高龄、男性、较高的Charlson合并症指数、较低社会经济地位(低收入、Medicaid和Medicare保险)、黑人种族和西班牙裔 ethnicity。
- 这些人群更可能在低手术量中心接受治疗。
关键数值与推荐
- 高手术量中心定义为手术量>第75百分位。
- pLOS的比值比为0.56(P<0.0001),30天死亡率的比值比为0.39(P<0.0001),均为高手术量中心 versus 低手术量中心。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Intracranial meningiomas are the most commonly diagnosed brain tumor in the United States. With increasing incidence, efficient allocation of limited health care resources is a critical component of emerging value-based models of care. The purpose of this study was to evaluate the effect of patient and hospital variables on metrics of value-based care. METHODS: The Statewide Planning and Research Cooperative System database was queried for records of patients undergoing intracranial meningioma surgery in New York State from 1995 to 2015. Multivariate logistic regression was used to investigate the effect of hospital volume and patient demographics on 30-day readmissions, 30-day mortality, prolonged length of stay (pLOS), and excess hospital charges. RESULTS: Among the 14,239 patients included, 10,252 (72%) cases were performed at high-volume centers (HVC) (>75th percentile). HVC were associated with lower rates of readmissions, mortality, and pLOS, but higher hospital charges. In the multivariate analysis, HVC had reduced odds of pLOS (odds ratio, 0.56; P < 0.0001) and 30-day mortality (odds ratio, 0.39; P < 0.0001). Patient variables associated with adverse outcomes in the multivariate model included advanced age, male gender, higher Charlson Comorbidity Index, lower socioeconomic status (low income, Medicaid, and Medicare insurance), black race, and Hispanic ethnicity. These populations were more likely to undergo treatment at lower-volume centers. CONCLUSIONS: This statewide population analysis of readmissions, mortality, length of stay, and hospital charges after intracranial meningioma surgery identified patient predictors of adverse outcomes. These determinants may be used by hospitals to develop improved systems of care in at-risk populations.
引用
- McKee SP, Yang A, Gray M, et al. Intracranial Meningioma Surgery: Value-Based Care Determinants in New York State, 1995-2015. World Neurosurg. 2018. PMID: 30010072. doi:10.1016/j.wneu.2018.07.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。